Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian A Rollins-Raval

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Journal of Clinical Apheresis|October 31, 2018
Hemostasis testing and therapeutic plasma exchange: Results of a practice surveyNicole D Zantek, Monica B Pagano, Marian A Rollins-Raval, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 10, 2021
Reduced cleavage of von willebrand factor by ADAMTS13 is associated with microangiopathic acute kidney injury following traumaWilliam E Plautz, Shannon H Haldeman, Mitchell R Dyer, et al.
Transfusion|March 10, 2025
Why do people still make anti-D over 50 years after the introduction of Rho(D) immune globulin? A Biomedical Excellence for Safer Transfusion (BEST) Collaborative studyRegina M DelBaugh, Michael F Murphy, Julie Staves, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Journal of Clinical Apheresis|October 31, 2018
Hemostasis testing and therapeutic plasma exchange: Results of a practice surveyNicole D Zantek, Monica B Pagano, Marian A Rollins-Raval, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 10, 2021
Reduced cleavage of von willebrand factor by ADAMTS13 is associated with microangiopathic acute kidney injury following traumaWilliam E Plautz, Shannon H Haldeman, Mitchell R Dyer, et al.
Transfusion|March 10, 2025
Why do people still make anti-D over 50 years after the introduction of Rho(D) immune globulin? A Biomedical Excellence for Safer Transfusion (BEST) Collaborative studyRegina M DelBaugh, Michael F Murphy, Julie Staves, et al.
Pageof 6